Details for Patent: 7,932,273
✉ Email this page to a colleague
Which drugs does patent 7,932,273 protect, and when does it expire?
Patent 7,932,273 protects PRADAXA and is included in two NDAs.
Protection for PRADAXA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has sixty-eight patent family members in thirty-five countries.
Summary for Patent: 7,932,273
Title: | 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1H-benzimidazol-5-carbonyl)pyridin-2-ylamino- ]propionic acid ethylester methansulfonate and its use as a medicament |
Abstract: | Ethyl 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl)phenylamino]methyl}-1-m- ethyl-1H-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate methanesulfonate in the crystalline modifications I and II and as the hemihydrate and the use thereof as a pharmaceutical composition. |
Inventor(s): | Schmid; Rolf (Baltringen, DE), Sieger; Peter (Mittelbiberach, DE), Sobotta; Rainer (Ingelheim am Rhein, DE) |
Assignee: | Boehringer Ingelheim International GmbH (Ingelheim, DE) |
Application Number: | 12/022,655 |
Patent Claim Types: see list of patent claims | Compound; Composition; |
Drugs Protected by US Patent 7,932,273
Foreign Priority and PCT Information for Patent: 7,932,273
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Germany | 103 39 862 | Aug 29, 2003 |
International Family Members for US Patent 7,932,273
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 045520 | ⤷ Try a Trial | |||
Argentina | 073225 | ⤷ Try a Trial | |||
Austria | 430145 | ⤷ Try a Trial | |||
Austria | 529420 | ⤷ Try a Trial | |||
Australia | 2004274139 | ⤷ Try a Trial | |||
Australia | 2010201457 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |